Human islets and dendritic cells generate post-translationally modified islet autoantigens

Clinical and Experimental Immunology

Volumn 185, Issue 2, 2016, Pages 133-140

  McLaughlin, R J ^a   de Haan, A ^a   Zaldumbide, A ^a   de Koning, E J ^b   de Ru, A H ^a   van Veelen, P A ^a   van Lummel, M ^a   Roep, B O ^a,c  

^a Department of Immunohematology and Blood Transfusion ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

DC; HLA; islets; post translational modification; type 1 diabetes

Indexed keywords

AUTOANTIGEN; C PEPTIDE; GAMMA INTERFERON; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INTERLEUKIN 1BETA; ISLET ANTIGEN 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEAMINATION; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

EID: 84978852701     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12775     Document Type: Article

References (33)

1. Coppieters KT, Dotta F, Amirian N et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 2012; 209:51–60.
2. Roep BO, Peakman M. Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes. Nat Rev Immunol 2010; 10:145–52.
3. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009; 155:173–81.
4. van Lummel M, Zaldumbide A, Roep BO. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2013; 20:299–306.
5. van de Wal Y, Kooy Y, van Veelen P et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161:1585–8.
6. van Lummel M, Duinkerken G, van Veelen PA et al. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes. Diabetes 2014; 63:237–47.
7. van Lummel M, van Veelen PA, Zaldumbide A et al. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire. J Biol Chem 2012; 287:9514–24.
8. Koeleman BP, Lie BA, Undlien DE et al. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun 2004; 5:381–8.
9. Pathiraja V, Kuehlich JP, Campbell PD et al. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes. Diabetes 2015; 64:172–82.
10. Russo L, Marsella C, Nardo G et al. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E. Acta Diabetol 2013; 50:61–72.
11. Hodrea J, Demeny MA, Majai G, Sarang Z, Korponay-Szabo IR, Fesus L. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages. Immunol Lett 2010; 130:74–81.
12. Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013; 13:566–77.
13. Mackern-Oberti JP, Llanos C, Vega F et al. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases. Autoimmun Rev 2015; 14:127–39.
14. Price JD, Tarbell KV. The role of dendritic cell subsets and innate immunity in the pathogenesis of type 1 diabetes and other autoimmune diseases. Front Immunol 2015; 6:288.
15. Gibson VB, Nikolic T, Pearce VQ, Demengeot J, Roep BO, Peakman M. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model. Clin Exp Immunol 2015; 182:251–60.
16. Kleijwegt FS, Jansen DT, Teeler J et al. Tolerogenic dendritic cells impede priming of naive CD8(+) T cells and deplete memory CD8(+) T cells. Eur J Immunol 2013; 43:85–92.
17. Ferreira GB, Kleijwegt FS, Waelkens E et al. Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. J Proteome Res 2012; 11:941–71.
18. Franken KL, Hiemstra HS, van Meijgaarden KE et al. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 2000; 18:95–9.
19. Zaldumbide A, Alkemade G, Carlotti F et al. Genetically engineered human islets protected from CD8-mediated autoimmune destruction in vivo. Mol Ther 2013; 21:1592–601.
20. van der Torren CR, Zaldumbide A, Roelen DL et al. Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy. Diabetologia 2016; 59:170–5.
21. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009; 6:359–62.
22. Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol 2009; 39:3147–59.
23. van Lummel M, van Veelen PA, Zaldumbide A et al. Type 1 diabetes associated HLA-DQ8-trans dimer accommodates a unique peptide repertoire. J Biol Chem 2012; 287:9514–24.
24. van Lummel M, van Veelen PA, de Ru AH et al. Discovery of a selective islet peptidome presented by the highest-risk HLA-DQ8trans molecule. Diabetes 2016; 65:732–41.
25. Roep BO, Kleijwegt FS, van Halteren AG et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010; 159:338–43.
26. Nepom GT, Kwok WW. Molecular basis for HLA-DQ associations with IDDM. Diabetes 1998; 47:1177–84.
27. Fuhlbrigge R, Yip L. Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis. Curr Diab Rep 2014; 14:525.
28. Guerder S, Joncker N, Mahiddine K, Serre L. Dendritic cells in tolerance and autoimmune diabetes. Curr Opin Immunol 2013; 25:670–5.
29. Paraskevas S, Maysinger D, Wang R, Duguid TP, Rosenberg L. Cell loss in isolated human islets occurs by apoptosis. Pancreas 2000; 20:270–6.
30. Sahraoui A, Kloster-Jensen K, Ueland T, Korsgren O, Foss A, Scholz H. Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation. Cell Transplant 2014; 23:1199–211.
31. Vader LW, de Ru A, van der Wal Y et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002; 195:643–9.
32. Robinson NE, Robinson ZW, Robinson BR et al. Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res 2004; 63:426–36.
33. Wright HT. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. Crit Rev Biochem Mol Biol 1991; 26:1–52.